Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Award jointly given to President and CEO Dr. Janice Nevin and Chief Digital and Information Officer Randy Gaboriault ChristianaCare has earned the Transformational Leadership Award for excelling in its development and deployment of transformational information technology that improves the delivery of care and streamlines administrative services. Presented by the College of Healthcare Information Management Executives (CHIME) and the American Hospital Association, the award is jointly bestowed to Janice Nevin, M.D., MPH, ChristianaCare’s president and CEO, and Randy Gaboriault, MS, MBA, ChristianaCare’s chief digital and information officer and senior vice president. “Their trailblazing commitment to rapid transformation has set an example for the entire industry in how to pursue a leadership vision with determination, brilliant planning and courage to overcome all challenges,” said CHIME President and CEO Russell P. Branzell. Under the leadership of Nevin and Gaboriault, ChristianaCare has created and deployed new organizational, digital capabilities for both patient and caregiver. Using voice-enabled technology, ChristianaCare HomeHealth patients can interact with an internally developed Alexa capability to guide them through their personalized daily therapy regimens. Similarly, ChristianaCare recently launched the ability for in-house postpartum patients to use an Amazon Echo device to ask questions, request help or communicate with their care team. Taking voice and digital capabilities further, in February 2022, ChristianaCare deployed an innovative tool called Moxi, a collaborative robot – or “cobot” – that can assist in the hospital by making deliveries and performing other non-clinical tasks so that nurses and other clinical caregivers can spend more time focused on what they do best: caring for patients. “Randy is a phenomenal leader, with a relentless focus on creating a culture of innovation for impact, solving for the most complex problems and delivering significantly improved outcomes,” Nevin said. “His work has made ChristianaCare a model for how transformative technology can help to create health so that every person can flourish.” ChristianaCare continues to be recognized for leading innovation in the health care industry. The organization was recently recognized by CHIME’s Most Wired program with Performance Excellence Awards in its acute and ambulatory categories. That level is reserved only for organizations that are considered leaders in health care technology who “actively push the industry forward” and are “realizing meaningful outcomes, including improved quality of care, improved patient experience, reduced costs and broader patient access to healthcare services.” “Under Dr. Nevin’s extraordinary leadership, we have made an intentional commitment to placing technology at the center of all our initiatives to enable our caregivers to best serve our patients,” Gaboriault said. “That commitment, reinforced by our organization’s core behavior to continuously look for new ways to innovate, means that we are able to introduce and leverage robotic nursing assistants in a way that drives meaningful value for both patients and providers. And because our caregivers embrace change, we are confident that we will be using our cobots to assume more tasks in the future, and enable our nurses to devote even more of their precious time to direct patient care.”
ChristianaCare Named a Most Wired Health Care Technology Leader for 7th Consecutive Year
For the seventh consecutive year, ChristianaCare has earned the “Most Wired” designation from the College of Healthcare Information Management Executives (CHIME), which assesses how effectively health care organizations apply core and advanced technologies to improve health and care in their communities. Among the more than 38,000 organizations surveyed by CHIME, ChristianaCare ranked above peers in categories such as analytics and data management, population health, infrastructure and patient engagement. The survey assessed the adoption, integration and impact of technologies in health care organizations at all stages of development, from early development to industry leading. “At ChristianaCare we are curious and continuously looking for ways to innovate,” said ChristianaCare President and CEO Janice E. Nevin, M.D., MPH. “Embedding that behavior in our organization has led to brilliant planning and extraordinary execution of new, technology-enabled models of care as our patients demand greater service and convenience, including greater access from home.” ChristianaCare was recognized with a Performance Excellence Award for Most Wired’s acute and ambulatory categories. That level is reserved only for organizations that are considered leaders in health care technology who “actively push the industry forward” and are “realizing meaningful outcomes, including improved quality of care, improved patient experience, reduced costs, and broader patient access to healthcare services.” “We are on the cutting edge of health care innovation, yet we have only scratched the surface of digital care,” said Randy Gaboriault, MS, MBA, chief digital and information officer at ChristianaCare. “We have embarked on building a digital distribution network of health care that strengthens every day. And we are guiding a digital thread that weaves together all the components in and outside the walls of the hospital and provider’s office to improve the health of every person we touch.” The Most Wired recognition highlights ChristianaCare’s success in the launch of the Hospital Care at Home program, which is transforming the very nature of how acute care is delivered, as well as the creation of digital platforms that radically improve the patient experience. Launched in December 2021, ChristianaCare’s Hospital Care at Home program offers the highest level of in-home acute care in Delaware. The program combines virtual and in-person care provided by a team of physicians, nurse practitioners, registered nurses and other providers, and has to date cared for more than 200 patients. These in-person and virtual visits from the health care team mean that a patient doesn’t need to leave home to get better. Virtual technology and home health equipment brought into the patient’s home ensure around-the-clock monitoring and care that mirror a traditional hospital setting. ChristianaCare’s digital patient engagement capabilities have streamlined nearly every aspect of the patient experience. Through these digital tools, the registration, check-in and intake of patients are becoming more streamlined, improving both patient experience and efficiency at ChristianaCare practices. The digital platform also enables patients to self-schedule appointments, easily complete their medical histories and check in to appointments by simply scanning a QR code with their digital device. “These digital offerings have placed our patients in the driver’s seat,” said Lynne McCone, MBA, chief applications officer and vice president of IT at ChristianaCare. “The benefits of a conducive, consistent patient journey and experience in turn improves practice operations and efficiency and dismantles administrative burdens for both patients and caregivers. It’s a huge win for consumers, patients and providers.” The Digital Health Most Wired survey and recognition program serves as a comprehensive “digital health check-up” for health care organizations across the world, according to CHIME. As success in digital health increasingly determines the quality of patient care, the scope of the CHIME Digital Health Most Wired survey reflects the progress of leading health systems, like ChristianaCare, as they reinvent health care for a new century. “We are proud to honor your team’s exceptional dedication to excellence in digital health,” said CHIME President and CEO Russell P. Branzell of ChristianaCare. “Your pioneering performance in the industry inspires other organizations by example. Patients in communities around the world receive better care when you drive change through digital transformation, as you have proven through your success in this rigorous program.”
Hearing clinic in partnership with Specsavers opens at Aston University
Hearing clinic opens to students, staff and NHS referrals Training of audiology students is supported by on-site clinic Free hearing tests made available in partnership with Specsavers. A new hearing clinic opened in the School of Optometry at Aston University is providing clinical care to students, staff and members of the public while supporting the training of Aston University audiology students. The clinic, which is situated on the ground floor in the Optometry building on the University campus in Birmingham city centre, is run in partnership with Specsavers and offers hearing tests for free. Aston University's audiology team is working with Specsavers to provide hearing tests, dispense hearing aids and also offer counselling and advice alongside a full aftercare package. The clinic can also advise people on personalised noise protection and ear plugs for swimming. It is open to members of the public and accepts NHS referrals. Claire Wilkes, audiology programme director at Aston University said: “So far the clinic has had a lot of interest and uptake of hearing appointments. We are delighted to be working alongside Specsavers. Many of our students undertake work placements with the company, so we are very happy we’ve been able to grow our partnership further by opening this clinic on campus.” Specsavers is a key partner of Aston University, with graduates from both audiology and optometry going on to work for them. Last year, 62% of students who were placed in Specsavers clinics for support and training applied for jobs on graduation and got to interview. Of those interviewed, 61% are now employed by Specsavers. Humah Zaheer, Specsavers audiology director, who runs the clinic added: “I’m delighted to be involved in this initiative. As an Aston University audiology graduate from 2014 it feels like I’ve come full circle. Being able to offer students an insight into the ‘real’ world of audiology, as well as Specsavers, is a fantastic experience for their career development. “We’ve also been bowled over with the response from the public and are looking to expand the number of days we open the clinic from next year.” The hearing clinic on campus will enable students to practice their clinical and communication skills in preparation for long term work placements off campus. The skills lab equipment mimics equipment in the NHS, helping students better prepare for placements. The hearing clinic is open from 9am until 5pm every Wednesday, Thursday and Friday with plans to increase to five days a week in the new year. To find out more or book an appointment visit our website. You can also call 0121 270 7072.
Birmingham MP officially opens £1.5 million healthcare simulation facilities at Aston University
Paulette Hamilton MP officially opens healthcare simulation facilities at Aston Medical School and School of Optometry State-of-the-art facilities including medical simulation room with high fidelity manikins for students to practise real life scenarios opens The first in Europe ocular simulation suite allows students to refine skills in examining the health of the eyes and experience a wide range of eye disease. New £1.5 million healthcare simulation facilities have officially opened at Aston Medical School and in the School of Optometry at Aston University. The state-of-the-art facilities were formally opened by Paulette Hamilton, member of parliament for Birmingham Erdington, on Friday 2 December at a ribbon cutting ceremony that was attended by Aston University Vice-Chancellor Professor Aleks Subic as well as other members of the University executive and staff from the College of Health and Life Sciences. Commenting on the new facilities Paulette Hamilton MP said: “It’s been brilliant to visit and officially open the new healthcare simulation facilities at Aston University. “I know from my time as a nurse how important it is to have access to good training and the latest equipment. These fantastic facilities will give students the best possible learning experience as they prepare to enter their profession, providing healthcare in Birmingham and beyond.” Hosted by Professor Anthony Hilton, Pro-Vice-Chancellor and Executive Dean of the College of Health and Life Sciences, guests were invited to take a tour of the new facilities including a clinical skills simulation room which allows students to practise in emergency settings and an ocular simulation unit facility, the only one in Europe. Professor Hilton said: "We are delighted these new facilities have opened in time for the start of the new term and that students can benefit from practising their clinical skills in a variety of scenarios. “The acute care simulation room will allow for simulated emergency resuscitation scenarios that are very difficult to teach in real life situations, such as heart attacks, acute breathlessness and severe allergic reaction and will be of great value in training students of medicine, pharmacy and optometry.” The healthcare simulation facilities will be used by students studying medicine, pharmacy and optometry, where they will be able to practise in emergency settings using high quality manikins where they will simulate treating patients for acute conditions such as a heart attack or learning how to intubate a patient onto a ventilator. Professor Aleks Subic, Vice-Chancellor, Aston University said: “The launch of the Aston University healthcare simulation facilities marks an important milestone in the development of our digital health precinct within the Birmingham Knowledge Quarter. By establishing world-class medical imaging, advanced visualisation, and digital diagnostics capabilities we are in fact bringing Industry 4.0 to healthcare. “Our students from the Aston Medical School and School of Optometry in particular, will benefit immensely from this development as they will be able to detect a wide range of clinical conditions and diseases and explore different interventions and scenarios, safely within a simulated environment.” The high-fidelity acute care simulation room will also be equipped with recording facilities, a debrief room and control room. The funding has allowed for the purchase of other training equipment such as a hospital grade bed and single task trainer simulation equipment. For example, male and female catheterisation models, pelvic and rectal trainers, venepuncture arms, breast trainers and abdominal trainers. The facilities were part funded by the Office for Students which awarded the University £806,226 to set up the ‘high fidelity’ simulation A&E room with further expenditure by Aston University on the ocular simulation unit. The ocular simulation facility is unique in Europe. It allows students to refine their skills in examining the health of the front and back of the eyes and to experience a wide range of eye disease. One of the simulators allows students to utilise their smartphones to practise at home. They can gain direct feedback and be assessed by the simulators, allowing more flexible, diverse and intensive learning than can be achieve with clinical practice placements. Professor Liz Moores, deputy dean of the College of Health and Life Sciences, said: “The College of Health and Life Sciences is thrilled with this investment. The enhanced facilities will help to support many of our healthcare students, including those now applying for our new nursing degree. It will also support us with the introduction of the new pharmacy and optometry education standards, providing a step change in our ability to simulate a wide range of clinical scenarios.” For more information about studying in the College of Health and Life Sciences please visit our website.
ChristianaCare Rated a High Performing Hospital for Maternity by U.S. News & World Report
ChristianaCare is the only health system in Delaware to earn the High Performing designation from U.S. News ChristianaCare has earned the highest award for maternity care that a hospital can achieve from U.S. News & World Report in its 2022-23 ratings for Best Hospitals for Maternity Care. Rated as a High Performing Hospital, ChristianaCare was the only health system in Delaware to earn this esteemed honor. Christiana Hospital at ChristianaCare’s Newark Campus is the only high-risk delivering hospital in the First State offering Level III neonatal intensive care. More than 6,100 babies are born at Christiana Hospital each year. The U.S. News Best Hospitals for Maternity Care methodology is based entirely on objective measures of quality, such as C-section rates in lower-risk pregnancies, newborn complication rates, exclusive breast milk feeding rates, early elective delivery rates and vaginal birth after cesarean (VBAC) rates, among other measures. “When we announced plans seven years ago to build the ChristianaCare Center for Women’s & Children’s Health, we affirmed our commitment to provide superior-quality care for women and infants in our region,” said Matthew Hoffman, M.D., MPH, FACOG, Marie E. Pinizzotto, M.D., Endowed Chair of Obstetrics and Gynecology at ChristianaCare. “This prestigious recognition is an affirmation that patients who choose to give birth at ChristianaCare will have access to the very best services and expertise to ensure a safe delivery and a healthy baby.” Just two years ago ChristianaCare opened the Center for Women’s & Children’s Health, an eight-story, approximately 400,000-square-foot tower at Christiana Hospital. The center uses the most up-to-date, evidence-based models of care, with improved integration of services and the space to offer innovative patient-centered care for mothers, babies and families. One of the most significant features of the new center is a state-of-the-art neonatal intensive care unit (NICU), featuring private rooms with sleep-in space for families. Christiana Hospital is one of the only hospitals in the United States to provide “couplet care” in the NICU, keeping the mother and baby together even if they both require medical care. This is based on a European model demonstrating that moms are more likely to breastfeed in this environment, which is particularly important in the early development of children. “We best achieve optimal health and flourish when we are able to begin our lives as healthy newborns,” said David Paul, M.D., chair of ChristianaCare’s Department of Pediatrics. “Building this transformative women’s and children’s hospital was a way to invest in the future of our community’s children. In addition to our outstanding caregivers and the care we provide within the walls of the hospital, this facility is a monumental step forward in enabling us to care for moms and babies, and we are delighted that U.S. News has recognized what a special place it is.” Other innovative features at the center include: Expanded labor and delivery suites. Private rooms for mothers and families after delivery. A spacious, multi-level Ronald McDonald Family Room to support families with infants who are in intensive care. Expanded OB/GYN emergency services area and new labor lounge. Separate admitting and discharge areas for the convenience of our patients. A tranquil family rooftop garden that provides spaces for play and relaxation. Vibrant sibling play spaces with interactive displays and artwork, and open community spaces for health education and programs. U.S. News’ annual evaluation is designed to assist expectant parents and their doctors in making informed decisions about where to receive maternity care. U.S. News evaluated nearly 650 hospitals that provide high-quality labor and delivery services for uncomplicated pregnancies for its 2022-2023 Best Hospitals for Maternity Care. Fewer than half of all hospitals that offer maternity care and participated in the survey received a High Performing designation. “When expectant parents are considering their options for welcoming a baby to the world, the Best Hospitals for Maternity Care are designed to help them identify hospitals that excel in delivering babies for uncomplicated pregnancies,” said Ben Harder, chief of health analysis and managing editor at U.S. News & World Report. “A hospital that has earned a High Performing designation may be a good option for parents, in consultation with their medical provider, to consider.” Excellence in Maternity Care Built on Experience and Research ChristianaCare’s Center for Women’s & Children’s Health includes Delaware’s most experienced maternity team, and it is also a significant research institution. Since opening, the Center for Women’s & Children’s Health participated in a significant study that found that treating mild chronic hypertension with medications is beneficial and safe for mother and baby. Published in The New England Journal of Medicine, the world’s foremost medical journal, the study has the potential to change the standard of care for some pregnant women, as it represented the first time that comprehensive, evidence-based data showed the benefits of treating mild forms of chronic hypertension during pregnancy. “Our commitment to research is a path to better caring for our community,” said Dr. Hoffman, a co-author in the study. About ChristianaCare Headquartered in Wilmington, Delaware, ChristianaCare is one of the country’s most dynamic health care organizations, centered on improving health outcomes, making high-quality care more accessible and lowering health care costs. ChristianaCare includes an extensive network of primary care and outpatient services, home health care, urgent care centers, three hospitals (1,299 beds), a freestanding emergency department, a Level I trauma center and a Level III neonatal intensive care unit, a comprehensive stroke center and regional centers of excellence in heart and vascular care, cancer care and women’s health. It also includes the pioneering Gene Editing Institute. ChristianaCare is nationally recognized as a great place to work, rated by Forbes as the 2nd best health system for diversity and inclusion, and the 29th best health system to work for in the United States, and by IDG Computerworld as one of the nation’s Best Places to Work in IT. ChristianaCare is rated by Healthgrades as one of America’s 50 Best Hospitals and continually ranked among the nation’s best by U.S. News & World Report, Newsweek and other national quality ratings. ChristianaCare is a nonprofit teaching health system with more than 260 residents and fellows. With its groundbreaking Center for Virtual Health and a focus on population health and value-based care, ChristianaCare is shaping the future of health care.
Aston University partners with paediatric pharmaceutical company to facilitate student research
• Aston University MSc Pharmaceutical Sciences, Drug Delivery and MPharm students work with industry professionals on research projects • Proveca pharmaceutical specialises in the development and licensing of medicines for children • Students will attend workshops led by Proveca and receive coaching on their research proposals. Aston University has partnered with pharmaceutical company Proveca to help support and facilitate final research projects being undertaken by its MSc Pharmaceutical Sciences, Drug Delivery and MPharm students. The partnership between the College of Health and Life Sciences at Aston University and Proveca began with a contract research project during which Professor Afzal Mohammed worked with Proveca to explore the development of drug formulation. Proveca is a pharmaceutical company specialising in the development and licensing of medicines for children. The company has now come on board to support and supervise at least five final year research projects and will help steer the students in the next steps in their lab research. The company will also support a wider number of students by running workshops, educating them on the current challenges of drug formulation development and providing coaching on how to write a research proposal. Professor Afzal Mohammed, associate head of pharmacy at Aston University, said: “This is a fantastic opportunity to enhance the student experience and build on our excellent industry focused teaching and research”. The projects are due to start in January 2023 and Proveca has agreed to sponsor the final project prize open to all of our MSc Pharmaceutical Sciences, Drug Delivery and final year MPharm students. Dr Simon Bryson, CEO and founder of Proveca Ltd, said: “We are delighted to be building on our relationship with Aston University, having collaborated over several years on a range of successful projects including PhD sponsorship and supervision, visiting lecturing and MPharm research awards. “The partnership brings together the academic excellence of Aston University with the paediatric pharmaceutical expertise of Proveca which will ultimately drive innovation in paediatric medicines to improve child health.” For more information about the School of Pharmacy at Aston University please visit our website.
Expert Q & A: Florida Tech faculty experts discuss the Artemis mission and why it matters
Artemis 1 Launch Starts New Lunar Exploration and Research The Artemis 1 mission has hit its halfway point. The uncrewed capsule Orion is orbiting the moon in the first spaceflight of NASA’s Artemis program. Over the entire Artemis program, NASA plans to establish the first long-term lunar presence via a base camp on the moon, then will use what was learned from the moon development for a mission to send the first astronauts to Mars. Founded as a school providing classes for the pioneering space technicians at what would become NASA, Florida Tech has been closely associated with the space program since its inception. The Artemis mission is no different, as over 25 Florida Tech alumni are working on the mission as part of the Exploration Ground Systems crew. We spoke with Florida Tech aerospace, physics and space sciences assistant professor Paula do Vale Pereira, Ph.D., and Don Platt, Ph.D., associate professor of space systems, about the Artemis mission, what it could mean for future missions and more. Q: What makes the Artemis rocket and mission significant? Pereira: The Space Launch System (or SLS for short) is the rocket that is central to the Artemis mission. The SLS will be the third rocket in history to be capable of launching humans to the Moon. Previously, the American Saturn V and Soviet N1 had that capability – none of the four N1 launch attempts were successful, though. Thus, the SLS could become the second rocket to ever fly humans to the Moon. The SLS has been under development for over a decade and one of its key technological differences from Saturn V is the focus on long-term, sustained access to the lunar surface. The SLS will power the Orion capsule to lunar orbit, where it will dock to the Lunar Gateway (currently under development). The Gateway will be a small space station orbiting the Moon and will have docking ports for the Orion capsule and different lander modules, such as SpaceX’s Starship. This coordinated infrastructure means that the SLS needs to carry only the Orion capsule and the crew, instead of having the carry the lander, command and service modules, as the Saturn V did. Because they don’t need to bring all these other modules with them, a larger quantity of useful equipment and extra crew members can be brought along, opening doors for a longer and even more productive human presence on the Moon. The SLS rocket also has other architectures which, instead of carrying humans, can carry large amounts of cargo to the Gateway, which can then be transferred to the lunar surface. This cargo capacity will be fundamental in building the infrastructure necessary for humans to strive on the Moon. Platt: Indeed, the SLS will be the largest launch vehicle ever flown and will put on a spectacular show on the Space Coast. This Artemis I mission will also test out the Orion capsule in deep space for an extended mission. The capability for the capsule to support human life in deep space will be demonstrated. As well, there are mannequins onboard Orion with radiation sensors in them. They will measure the radiation exposure in deep space and around the Moon to help verify how much radiation human astronauts may be exposed to. And I would add, much like the shuttle opened up Low Earth Orbit for all of humanity, Artemis will do the same for lunar exploration. Q: What is the significance of Artemis to NASA-sponsored space exploration? Platt: Artemis is the next major NASA human space program. It is also NASA’s first program to go back to the Moon since Apollo. It is designed to be the first in multiple efforts to expand human presence in space beyond Low Earth Orbit. It is also significant in that it has a goal to land the first woman and first person of color on the Moon. So, this is an inclusive program to hopefully involve all of humanity in future human space exploration and one day settlement. Q: How can moon-orbiting mission of Artemis help future space exploration? Platt: We need to demonstrate modern capabilities to get large spacecraft that can support human exploration to the Moon. The first step is to place them in orbit to test them out and soon to get astronauts experience in that environment as well. Much like Apollo 8 first orbited the Moon before humans landed on the Moon in Apollo 11 we are now testing and demonstrating new technology and capabilities first in lunar orbit. Pereira: I personally think the most important development in the Artemis mission is the coordination between different providers, especially the commercial partnership with companies such as SpaceX, Blue Origin and Lockheed Martin. The commercial partners will provide the lander systems which will take the astronauts from the Lunar Gateway to the lunar surface, a level of dependable trust that has only recently started to be common in NASA’s history. If you're a reporter looking to know more about this topic, let us help. Dr. Platt is available to speak with media regarding this and related topics. Simply click on his icon now to arrange an interview today. Contact Director of Media Communications Adam Lowenstein at adam@fit.edu to schedule an interview with Dr. do Vale Pereira.
Preterm Birth and Lifelong Health
November is Prematurity Awareness Month—a month that places a spotlight on the current state of maternal and infant health in the United States and globally. According to the nonprofit March of Dimes, one in 10 babies is born preterm each year in the U.S. But what does that mean, and why do we need to consider gestation period post-birth? We sat down with Michelle Kelly, PhD, CRNP, CNE, FAANP, associate professor of nursing at Villanova University's M. Louise Fitzpatrick College of Nursing, to discuss and explain the importance of preterm education for lifelong health. Q: To begin, what qualifies as preterm birth? Dr. Kelly: A full-term pregnancy lasts 40 weeks. Infants born before the completion of 37 weeks of gestation are preterm. And there are levels of prematurity: Extremely preterm: Infants born before the completion of 25 weeks of gestation. Very preterm: Infants born before the completion of 32 weeks of gestation. Moderately preterm: Infants born between 32-34 weeks of gestation. Late preterm: Infants born between 34-36 weeks of gestation. Q: Why do health practitioners need to be aware of gestation history? DK: Understanding the potential long-term physical and mental health implications is essential to mitigating the risks. Clinicians cannot change the reality that someone was born early. However, clinicians can utilize that information in treatment decisions. Instituting treatment or therapies early can help minimize the expression of that risk and improve future health. Q: What are the health risks for children born prematurely? DK: The earlier an infant is born, the greater the risk to their overall health and development. And while it is much better to be born at 35 weeks instead of 25 weeks, it does not mean that those born closer to term escape all risks. During infancy and childhood, a preterm birth can cause difficulty with breathing, feeding, gaining weight appropriately and achieving important developmental milestones. Research suggests that children and adolescents born at any level of prematurity are at risk for challenges in school, conditions that require physical or behavioral therapy as well as conditions typically associated with immature body systems, such as respiratory issues like asthma. Additionally, long-term follow-up studies indicate that risk continues into adolescence and adulthood. Q: What are some long-term issues that stem from being born preterm? DK: Adolescents and adults born preterm continue to be at risk for reduced lung function, wheezing and asthma. Research findings suggest that there are also cardiovascular risks, particularly an increased incidence of hypertension (high blood pressure). Additionally, an increased incidence of mental health conditions, specifically anxiety and depression, are associated with preterm birth. All these increased risks are modifiable with early recognition and treatment. Q: What recent research has been conducted and what strides have been made to improve the lives of those born preterm? Is the prognosis for those born preterm positive? DK: Today's NICU environment is vastly different from the NICU of the past. Premature babies born in the last 20 years have survival rates that exceed 95 percent for all but the earliest of gestational ages. Increased attention to developmentally supportive care, breastfeeding, kangaroo care and the recognized importance of family presence in the NICU is now the standard of care. Research and advocacy aimed at supporting families touched by prematurity and raising awareness of healthcare providers and K-12 educators are gaining international attention. While being born preterm presents lifelong risks, identifying and communicating one's status with health practitioners early and often allows for effective treatment and positive outcomes.
Researchers awarded £2 million to develop drugs to prevent epileptic seizures in children
• Three-year research project to develop new drug treatments for childhood epilepsy • Scientists will test new treatment on pieces of living brain tissue • The research is a collaboration between Aston University, Bristol University and Jazz Pharmaceuticals. Scientists at Aston University have started work on a project that will look for new drug treatments to prevent the onset of childhood epilepsy. The three-year Medical Research Council (MRC) funded project is a collaboration led by researchers in the College of Health and Life Sciences at Aston University, partnered with Bristol University and Jazz Pharmaceuticals. They have been awarded £2 million to explore how epilepsy becomes established in the brain and how this process might be prevented. The researchers will test new drugs in the human brain, using samples of living tissue taken from children with difficult to treat epilepsies who have had to have brain surgery. Epilepsy is a brain disease which is characterised by seizures. As Professor Gavin Woodhall, lead researcher and co-director of Aston Institute of Health and Neurodevelopment, explains: “Seizures are periods of time when networks of brain cells are too active and are uncontrollably excited and spiking. If uncontrolled excitation spreads to brain regions that control movement, then too many brain cells are ‘talking at the same time’ and we can see seizures as changes in movement such as jerks and twitches.” Upon receiving the grant, Professor Woodhall said: “We will be able to study epilepsy in such detail that we hope to be able to treat the problems that underly epilepsy and not just the seizures themselves. And this could help pave the way to prevent epilepsy from developing in children at all. “Essentially we want to find a treatment that stops the brain from being able to establish epilepsy after the first seizure - via a new drug treatment. We will be testing a known drug and a new drug to see if the drug can do this.” As part of the research for this project the scientists will look at how different amounts of epileptic activity in the brain can alter the brain’s excitability. The researchers predict that if there are a lot of seizures, the synapses in the brain will decrease their activity and brain cells will become more likely to spike. Professor Woodhall added: “This is why we will test antiepileptic drugs, and new drugs designed to interfere with homeostatic scaling - which is a form of plasticity, in which the brain responds to chronically elevated activity in a neural circuit with negative feedback, allowing individual neurons to reduce their overall action potential firing rate. “By interfering with homeostatic scaling we will be able to see if they can prevent seizures from developing or reducing their intensity.” The research will allow Professor Woodhall and his team to be able to record the life history of the disease. This is something which has not been done before in this level of detail and it is predicted it will help to shed light on how epilepsy initially develops in the brain. Following on from the three-year project the team will move into drug development and then clinical trial. For more information about research being undertaken at AIHN please go to our website. If you are interested in the courses we have available in this area please go to our course pages.
• University expert helps clothes designer measure and tackle their carbon emissions • Upcycler, ‘Missfit Creations’, has saved CO2 equivalent of three tonnes • Call to COP27 to issue a protocol to measure all garments’ environmental impact. 8 November 2022 | Birmingham UK As policymakers at COP27 are to discuss the effects of the fashion industry on the environment, an Aston University scientist has been helping a clothes designer measure and tackle their carbon emissions. Debbie Murphy runs Missfit Creations which provides an alternative to fast fashion. She saves clothes from clogging up landfill by restoring and reworking second-hand and vintage clothing, from de-mob suits and 1970s psychedelia, to the present day. Dr Maria Pimenta da Costa Ocampo, a researcher from the Energy & Bioproducts Research Institute (EBRI) at Aston University, has been identifying the impact the business is having on reducing carbon emissions. By analysing the recirculation of second-hand clothes alone, she found Debbie’s current fashion collection has the potential to save the CO2 equivalent of three tonnes – equal in size to at least three semi-detached houses. The support provided to Tamworth-based Missfit Creations was through EBRI's European Regional Development Fund (ERDF) programme that helps West Midlands companies develop low carbon goods and services. Debbie said: “It was eye-opening to work with Aston University. “I collect and restore a huge amount of old, unwanted clothes that would otherwise have ended up in landfill, so I decided to find out what impact my business has on the environment. “I knew my business would help tackle the effects of fast fashion, but I didn’t realise I’ve been able to prevent the production of so much CO2. “Raising awareness of second-hand clothes over fast fashion, and the increased awareness of clothing care efficiency will help reduce the carbon footprint of the textile industry.” The Aston University report also suggests ways the business can further decrease emissions. As a result, it will be introducing a ‘take-back’ scheme, offering vouchers or exchanges in return for previous purchases. Debbie will also be changing production methods by ensuring all packaging is biodegradable, ironing fabrics less and switching to a more sustainable energy provider. The COP27 fashion charter event (11 November 2022) will explore whether the sector’s planned transformation to net zero is underway, practical solutions that are being applied and what is needed to achieve the goal. However, Dr Pimenta-Ocampo said: “Every single action taken towards the production and recirculation of clothing has an environmental impact. “For example, we calculated that by recirculating vintage clothing, Missfit Creations was reducing CO2 equivalent by almost two tonnes just by diverting clothes from landfill. “And by outsourcing their vintage clothes for cleaning services that don’t use tumble driers, not taking into account transport emissions, Missfit Creations is reducing CO2 equivalent by another one tonne. “There is a great need for the textile industry to monitor and provide accurate data and to become more transparent, specially when global supply chains are involved. “However, the creation of a protocol and standardisation of the Life Cycle Assessment, which measures a product’s environmental impact from raw material to final disposal, is also required. Without it, it will be impossible to produce results that can be representative.”
